Abstract dark red curved lines background

Is Psychedelic-Assisted Therapy Legal in New York City?

Is Psychedelic-Assisted Therapy Legal in New York City?

Psychedelic-assisted therapy is an increasingly popular topic of discussion in treatment circles, but its legality in New York City and beyond remains an open question. Understanding when this treatment option is available is critical to understanding both business and treatment decisions. Federal controlled substance laws and New York regulations interplay in this complicated area. 

The attorneys at Daniels, Porco & Lusardi, LLP are highly experienced New York healthcare law attorneys. We help you explore your options and maintain legal compliance. Get in touch today to learn more. 

Federal and State Controlled‑Substance Laws

Most psychedelics remain as Schedule I controlled substances under federal law, including:

  • Psilocybin
  • MDMA
  • LSD
  • DMT
  • Mescaline

A schedule I substance is defined as having no accepted medical use, but has a high potential for abuse. Because of this status, possession or distribution of these substances is illegal outside of specifically approved research. Physicians cannot prescribe these substances as treatment, even in a therapeutic setting.

New York State mirrors federal scheduling. There is no state‑level legalization or medical‑use carve‑out for psilocybin or MDMA. New York City does not and cannot separately authorize this type of treatment. Psychedelic-assisted therapy is not approved except in approved clinical trials. 

What Is Legal: Ketamine‑Assisted Therapy

Most psychedelics remain prohibited for treatment, but ketamine is different. Ketamine is a Schedule III controlled substance. The FDA has approved it for anesthesia and is often used off-label for mental health purposes. Ketamine-assisted therapy is legal in New York City and the rest of the state, if it is delivered within very strict rules. 

  • Diagnosis and treatment planning by a licensed physician.
  • Proper licensure: New York medical license, DEA registration, and New York controlled‑substance license.
  • Safe administration protocols, including monitoring, emergency equipment, and documented informed consent.
  • Compliance with New York’s Prescription Monitoring Program and controlled‑substance recordkeeping rules.

Ketamine clinics also have to follow New York’s very strict Corporate Practice of Medicine rules. Only physicians are allowed to control medical decision-making aspects, with strict limitations elsewhere in the structure as well. Guidance from a skilled New York medical transaction attorney is highly recommended to keep your practice compliant. 

Clinical Trials and Research Pathways

Although Schedule I psychedelics cannot be used in routine care, New York City hosts multiple research institutions conducting FDA‑regulated studies. Participation in these trials is legal because:

  • The DEA issues research registrations.
  • The FDA approves study protocols.
  • Substances are stored, handled, and administered under strict federal controls.

NYC residents may legally receive psilocybin or MDMA only as part of an authorized clinical trial. These programs do not constitute general medical availability and cannot be offered commercially.

Professional‑Practice and Advertising Restrictions

Even when discussing legal ketamine services or research participation, NYC providers must follow strict rules:

  • No claims that psilocybin or MDMA therapy is “legal,” “approved,” or “available” outside research.
  • No promises of cures or guaranteed outcomes.
  • No marketing that implies FDA approval for mental‑health uses of ketamine.
  • No offering of “psychedelic integration therapy” that suggests access to illegal substances.

Therapists may provide harm‑reduction or integration counseling, but they cannot facilitate, encourage, or appear to coordinate illegal psychedelic use.

Future Legal Developments

Things can always change. There is increasing interest in MDMA and psilocybin treatment federally and at the state level. If the FDA would approve either substance, New York would also need to update its laws to account for that change. Knowing how to proceed would require careful navigation of federal and state law. 

As of today, no psychedelic other than ketamine is approved or legal for therapeutic use in NYC.

Learn More About Psychedelic-Assisted Therapy Options in New York City

For now, ketamine treatment is available in a highly regulated environment, but other options may become available as the law changes. You want to be ready when it does. Having a legal team in your corner protects your practice and increases your ability to do business in this evolving area. 

The attorneys at Daniels, Porco & Lusardi, LLP are ready to help. Contact us today for a consultation.